Wellgistics Health (WGRX) Stock Price, News & Analysis

Company Overview

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. In January 2023 and May 2023, Wellgistics Health entered into separate definitive agreements with the owners of Wood Sage and Wellgistics LLC, respectively, whereby Wellgistics Health would acquire all of the respective outstanding membership interests of Wood Sage and Wellgistics LLC. In June 2024, Wellgistics Health and Wood Sage entered into an amended and revised definitive agreement and closed on the Wood Sage Acquisition, thereby making Wood Sage a wholly owned subsidiary of Wellgistics Health. In connection with the Wood Sage Acquisition, Wellgistics Health acquired Wood Sage’s two operating subsidiaries, APS—a pharmaceutical technology hub—and CSP—a retail community specialty pharmacy. On August 30, 2024, Wellgistics Health closed on the Wellgistics Acquisition, thereby making Wellgistics LLC—a company focused on wholesale operations including the distribution and fulfillment of certain pharmaceutical medications to a network of independent pharmacies meant to improve market access to and patient outcomes regarding the medications—a wholly owned subsidiary of Wellgistics Health. As such, Wellgistics Health currently exists as a holding company with Wood Sage as a directly held intermediate holding company subsidiary, APS and CSP as indirect operating subsidiaries, and Wellgistics LLC as a direct operating subsidiary. On October 4, 2024, the Company changed its corporate name to “Wellgistics Health, Inc.” by filing a duly authorized Certificate of Amendment to its Certificate of Incorporation. Despite that Wellgistics Health only recently closed the Wood Sage Acquisition and the Wellgistics Acquisition during 2024, the three companies have shared common office space, comarketed solutions to the marketplace, and leveraged financial and back-office support prior to June 2024. As such, Wellgistics Health’s management believes that its close business relationships have and will continue to limit the need for post-closing integration. The mailing address of our principal executive office is 3000 Bayport Drive, Suite 950 Tampa, FL.

Key Stats

• Today's Range: $0.09 to $0.11
• 50-Day Range: $0.09 to $0.24
• 52-Week Range: $0.09 to $7.04
• Volume: 3.71 million shs
• Average Volume: 30.26 million shs
• Market Capitalization: $11.78 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Wellgistics Health Stock Analysis - MarketRank™

Wellgistics Health scored higher than 3% of companies evaluated by MarketBeat, and ranked 850th out of 857 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Wellgistics Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Wellgistics Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Wellgistics Health is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Wellgistics Health is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

22.42% of the float of Wellgistics Health has been sold short.

Short Interest Ratio / Days to Cover

Wellgistics Health has a short interest ratio ("days to cover") of 0.28, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Wellgistics Health has recently increased by 450.49%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Wellgistics Health does not currently pay a dividend.

Dividend Growth

Wellgistics Health does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for WGRX on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Wellgistics Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

44.94% of the stock of Wellgistics Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Wellgistics Health has minimal institutional ownership at this time.

WGRX Stock Analysis - Frequently Asked Questions

How have WGRX shares performed this year?

Wellgistics Health's stock was trading at $0.40 on January 1st, 2026. Since then, WGRX stock has decreased by 76.8% and is now trading at $0.0930.

How were Wellgistics Health's earnings last quarter?

Wellgistics Health, Inc. (NASDAQ:WGRX) released its quarterly earnings results on Tuesday, August, 19th. The company reported ($0.11) earnings per share for the quarter. The firm earned $7.79 million during the quarter. Wellgistics Health had a negative net margin of 433.95% and a negative trailing twelve-month return on equity of 1,617.25%.

When did Wellgistics Health IPO?

Wellgistics Health (WGRX) raised $4 million in an initial public offering (IPO) on Friday, February 21st 2025. The company issued 900,000 shares at a price of $4.50-$5.50 per share. Craft Capital and D. Boral Capital (ex-EF Hutton) acted as the underwriters for the IPO.

How do I buy shares of Wellgistics Health?

Shares of WGRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 8/19/2025
• Today: 5/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Wholesale
• Current Symbol: NASDAQ:WGRX
• CIK: 2030763
• Web: N/A
• Phone: 1-843-302-1785
• Fax: N/A
• Employees: 31
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($1.44)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$101.28 million
• Net Margins: -433.95%
• Pretax Margin: -433.95%
• Return on Equity: -1,617.25%
• Return on Assets: -175.38%

Debt

• Debt-to-Equity Ratio: 1.86
• Current Ratio: 0.09
• Quick Ratio: 0.04

Sales & Book Value

• Annual Sales: $23.34 million
• Price / Sales: 0.50
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.14) per share
• Price / Book: -0.66

Miscellaneous

• Outstanding Shares: 126,650,000
• Free Float: 69,735,000
• Market Cap: $11.78 million
• Optionable: N/A
• Beta: -1.17